技師長承認

Q31 F1 論文記録

年

月印日委員会審査

年

月印日

記録作成

年

月印
日

英文原著
1. Sasaki K，Uchiumi T，Toshima T，Yagi M，Do Y，Hirai H，Igami K，Gotoh K，Kang
D（2020）Mitochondrial translation inhibition triggers ATF4 activation，leading
to integrated stress response but not to mitochondrial unfolded protein
response，Bioscience reports 40．
2. Shiota M，Fujimoto N，Yamamoto Y，Takeuchi A，Tatsugami K，Uchiumi T，Matsuyama
H，Eto M（2020）Genome-wide association study of genetic variations associatedwith treatment failure after intravesical bacillus Calmette-Guerin therapy fornon-muscle invasive bladder cancer，Cancer Immunol Immunother 69，1155-63．
3. Yokomizo A，Setoyama D，Terasawa A，Hotta T，Kang D，Kogawa K，Anzai K，Hitoshi
Katsuta H（2020）Machine-learning Algorithm for Predicting Serious Ketoacidosis
in Type-2 Diabetic Patients Using Clinical Test Profiles ，Clin Chem 322008．
4. Sakata A，Mukae N，Morioka T，Tanaka S，Shimogawa T，Shigeto H，Hotta T，Kang
D ， Mizoguchi M （ 2020 ） Simultaneous electroencephalographic andelectocorticographic recordings of lateralized periodic discharges in temporal
lobe epilepsy，Clin EEG Neurosci 1550059420972260．
5. Shirozu N，Morioka T，Tokunaga S，Shimogawa T，Inoue D，Arihiro S，Sakata A，Mukae N，Haga S，Iihara K（2020）Comparison of pseudocontinuous arterial spinlabeling perfusion MR images and time-of-flight MR angiography in the detectionof periictal hyperperfusion，eNeurologicalSci 19．
6. Akamine S，Okuzono S，Yamamoto H，Setoyama D，Sagata N，Ohgidani M，Kato TA，Ishitani T，Kato H，Masuda K，Matsushita Y，Ono H，Ishizaki Y，Sanefuji M，SaitsuH，Matsumoto N，Kang D，Kanba S，Nakabeppu Y，Sakai Y，Ohga S（2020）GNAO1 organizes
the cytoskeletal remodeling and firing of developing neurons，FASEB J 34，16601-21．
7. Gotoh K，Kunisaki Y，Mizuguchi S，Setoyama D，Hosokawa K，Yao H，Nakashima Y，Yagi M，Uchiumi T，Semba Y，Nogami J，Akashi K，Arai F，Kang D（2020）Mitochondrial
Protein Synthesis Is Essential for Terminal Differentiation of CD45(-)
TER119(-)Erythroid and Lymphoid Progenitors，iScience 23，101654．
8. Yoshihiro S，Ishigaki T，Ookurano H，Yoshitomi F，Hotta T，Kang D，Hokazono E，Kayamori Y（2020）New colorimetric method with bromocresol purple for estimating
the redox state of human serum albumin，J Clin Biochem Nutr 67，257-262．
9. Ueki K，Wakisaka Y，Nakamura K，Shono Y，Wada S，Yoshikawa Y，Matsukuma Y，Uchiumi T，Kang D，Kitazono T，Ago T（2020）Mitochondrial myopathy，encephalopathy，

2009 年 8 月 24 日改訂

1/4

九州大学病院検査部

Q31 F1 論文記録

lactic acidosis，and stroke-like episodes due to m.3243A > G mutation in a 76year-old woman，J Neurol Sci 412，116791．
10. Ueki K，Nakamura K，Wakisaka Y，Wada S，Yoshikawa Y，Matsumoto S，Hotta T，KangD，Kitazono T，Ago T（2020）An Embolic Stroke in a Patient With PROC p.Lys193del，
J Stroke Cerebrovasc Dis 29，104597．
11. Ohashi I，Wada S，Yoshino F，Kuwashiro T，Matsumoto S，Hotta T，Kang D，Okada
Y，Shimohama S，Yasaka M（2020）Ischemic Stroke with Protein S Deficiency Treatedby Apixaban，J Stroke Cerebrovasc Dis 29，104608．
12. Saku T，Takashio S，Tsuruta Y，Otsuka Y，Takae M，Kiyama T，Yamamoto E，KaikitaK，Hotta T，Matsumoto S，Kang D，Tsujita K，Komohara Y（2020）Comparison ofelectron microscopic findings and clinical presentation in three patients withmitochondrial cardiomyopathy caused by the mitochondrial DNA mutation m.3243A> G，Med Mol Morphol．
13. Do Y，Matsuda S，Inatomi T，Nakada K，Yasukawa T，Kang D（2020）The accessory
subunit of human DNA polymerase gamma is required for mitochondrial DNA
maintenance and is able to stabilize the catalytic subunit，Mitochondrion 53，
133-9．
14. Fang Y，Akimoto M，Mayanagi K，Hatano A，Matsumoto M，Matsuda S，Yasukawa T，Kang D（2020）Chemical acetylation of mitochondrial transcription factor A
occurs on specific lysine residues and affects its ability to change global
DNA topology，Mitochondrion 53，99-108．
15. Igami K，Uchiumi T，Ueda S，Kamioka K，Setoyama D，Gotoh K，Akimoto M，Matsumoto
S，Kang D（2020）Characterization and function of medium and large extracellular
vesicles from plasma and urine by surface antigens and Annexin V， PeerJ
Analytical Chemistry 2，e4．
16. Itsumi M，Shiota M，Sekino Y，Ushijima M，Kashiwagi E，Takeuchi A，Inokuchi J，Kajioka S，Uchiumi T，Eto M（2020）High-throughput screen identifies 5-HT receptor
as a modulator of AR and a therapeutic target for prostate cancer，Prostate
80，885-94．
17. Tsuda H，Noguchi K，Oh D，Bereczky Z，Lee LH，Kang D，Dusse LMS，das G Carvalho
M，Morishita E（2020）Racial differences in protein S Tokushima and two protein
C variants as genetic risk factors for venous thromboembolism，Res Pract Thromb
Haemost 4，1295-300．
18. Ahmed K，Dony JJF，Mori D，Haw LY，Giloi N，Jeffree MS，Iha H（2020）An outbreakof gastroenteritis by emerging norovirus GII.2[P16] in a kindergarten in Kota

2009 年 8 月 24 日改訂

2/4

九州大学病院検査部

Q31 F1 論文記録

Kinabalu, Malaysian Borneo，Sci Rep

10，7137．

19. Erabi H，Okada G，Shibasaki C，Setoyama D，Kang D，Takamura M，Yoshino A，Fuchikami
M，Kurata A，Kato TA，Yamawaki S，Okamoto Y（2020）Kynurenic acid is a potential
overlapped biomarker between diagnosis and treatment response for depression
from metabolome analysis，Sci Rep 10，16822．
20. Jeffree MS，Mori D，Yusof NA，Atil AB，Lukman KA，Othman R，Hassan MR，Suut L，Ahmed K （ 2020 ） High incidence of asymptomatic leptospirosis among urban
sanitation workers from Kota Kinabalu, Sabah, Malaysian Borneo，Sci Rep 10，19442．
21. Yamanashi T，Iwata M，Shibushita M，Tsunetomi K，Nagata M，Kajitani N，MiuraA，Matsuo R，Nishiguchi T，Kato TA，Setoyama D，Shirayama Y，Watanabe K，Shinozaki
G，Kaneko K（2020）Beta-hydroxybutyrate，an endogenous NLRP3 inflammasome
inhibitor，attenuates anxiety-related behavior in a rodent post-traumaticstress disorder model，Sci Rep 10，21629．
22. Abe K，Mukae N，Morioka T，Sangatsuda Y，Sakata A，Suzuki S，Mizoguchi M（2020）
Nonconvulsive status epilepticus associated with Alzheimer’s disease mimickingsymptomatic focal epilepsy following the resection of a frontal parasagittal
meningioma，Surg Neurol Int 11，469．
23. Shiota M，Endo S，Fujimoto N，Tsukahara S，Ushijima M，Kashiwagi E，Takeuchi
A，Inokuchi J，Uchiumi T，Eto M（2020）Polymorphisms in androgen metabolism genes
with serum testosterone levels and prognosis in androgen-deprivation therapy，Urol Oncol 38，849．

2009 年 8 月 24 日改訂

3/4

九州大学病院検査部

Q31 F1 論文記録

和文原著
1. 瀬戸山大樹．
（2020）臨床検査診断支援システム(DSS)の開発を目指した検査値データの活用事例について，日本医療検査科学会誌 45，165-171．
2. 服部佳奈子，木部泰志，諸熊由子，清祐麻紀子，西田留梨子，下野信行，堀田多恵子，康東天．（2020）VITEK MS で Neisseria meningitidis と誤同定された Neisseria
polysaccharea と Neisseria meningitidis との鑑別法および VITEK MS の同定精度の検証，日本医療検査科学会誌 45，222-229．
3. 曽川一幸，清祐麻紀子，服部佳奈子，村田正太，渡智久，奥村元，関口幸恵，藤永あず
み，中山智祥．
（2020）質量分析装置 Matrix-assisted laser desorption／ionization
time-of-flight mass spectrometry の細菌同定における内部精度管理実施要綱の検討，
日本医療検査科学会誌 45，255-259．
4. 松本信也，野田望，藤本明子，渡邉久美子，堀田多恵子，内海健，康東天．
（2020）乳幼児期の血栓症症例においてプロテインＳ活性に対するプロテインＣ活性の比でプロテインＣ遺伝子バリアントの有無を推測できる，臨床病理 68，883-888．

和文総説
1. 小森圭司，伊原栄吉，後藤和人，康東天，小川佳宏．（2020）機能性ディスペプシアと十二指腸粘膜バリア機能障害，日本臨床生理学会雑誌 50，7-13．
2. 後藤和人，康東天．
（2020）樹状細胞の成熟化におけるミトコンドリア p32 の役割，臨
床化学 49，117-123．

著書
1. Yasukawa T，Matsuda S，Kang D．（2020）Chapter 3 - Epigenetic features of
mitochondrial DNA，The Human Mitochondrial Genome，71-85．
2. 瀬戸山大樹，加藤隆弘．
（2020）診断バイオマーカー発の試み，精神科（心療内科） 37，592-598．

うつ病の血液バイオマーカー開3. 清祐麻紀子．
（2020）バイテック MS の導入とその臨床的な有用性，臨床と微生物
13-17．

47，

4. 清祐麻紀子．
（2020）見直そう、日常微生物検査 －その課題と解決策を考える 検体採取・輸送・保存，臨床と微生物 47，499-506．

2009 年 8 月 24 日改訂

4/4

九州大学病院検査部